Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3

[1]  P. Sexton,et al.  Identification of molecular phenotypes and biased signaling induced by naturally occurring mutations of the human calcium-sensing receptor. , 2012, Endocrinology.

[2]  J. Connell,et al.  Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites. , 2012, Human molecular genetics.

[3]  Jai Radhakrishnan,et al.  Mutations in Kelch-like 3 and Cullin 3 cause hypertension and electrolyte abnormalities , 2012, Nature.

[4]  A. Cavanaugh,et al.  Agonist-Driven Maturation and Plasma Membrane Insertion of Calcium-Sensing Receptors Dynamically Control Signal Amplitude , 2011, Science Signaling.

[5]  S. Burtey,et al.  High Resolution Melt analysis for mutation screening in PKD1 and PKD2 , 2011, BMC nephrology.

[6]  Hugo Y. K. Lam,et al.  Performance comparison of exome DNA sequencing technologies , 2011, Nature Biotechnology.

[7]  Stuart M. Baddeley,et al.  Gamma-aminobutyric acid type B (GABA(B)) receptor internalization is regulated by the R2 subunit. , 2011, The Journal of biological chemistry.

[8]  Martin Goodson,et al.  Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. , 2011, Genome research.

[9]  Stuart M. Baddeley,et al.  γ-Aminobutyric Acid Type B (GABAB) Receptor Internalization Is Regulated by the R2 Subunit* , 2011, The Journal of Biological Chemistry.

[10]  Stuart M. Baddeley,et al.  GABAB receptor internalisation is regulated by the R2 subunit , 2011 .

[11]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[12]  M. Nesbit,et al.  Identification of a second kindred with familial hypocalciuric hypercalcemia type 3 (FHH3) narrows localization to a <3.5 megabase pair region on chromosome 19q13.3. , 2010, The Journal of clinical endocrinology and metabolism.

[13]  L. Muscarella,et al.  Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years. , 2010, The Journal of clinical endocrinology and metabolism.

[14]  I. Grigorieva,et al.  A missense GATA3 mutation, Thr272Ile, causes the hypoparathyroidism, deafness, and renal dysplasia syndrome. , 2009, The Journal of clinical endocrinology and metabolism.

[15]  E. Prossnitz,et al.  Adaptor Protein‐2 Interaction with Arrestin Regulates GPCR Recycling and Apoptosis , 2009, Traffic.

[16]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[17]  Sharon E. Miller,et al.  A structural explanation for the binding of endocytic dileucine motifs by the AP2 complex , 2008, Nature.

[18]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[19]  J. Vázquez-Prado,et al.  Calcium-sensing receptor endocytosis links extracellular calcium signaling to parathyroid hormone-related peptide secretion via a Rab11a-dependent and AMSH-sensitive mechanism. , 2007, Molecular endocrinology.

[20]  H. Ohno.  Physiological roles of clathrin adaptor AP complexes: lessons from mutant animals. , 2006, Journal of biochemistry.

[21]  M. A. Edeling,et al.  Molecular switches involving the AP-2 beta2 appendage regulate endocytic cargo selection and clathrin coat assembly. , 2006, Developmental cell.

[22]  M. Lyon,et al.  Activating calcium-sensing receptor mutation in the mouse is associated with cataracts and ectopic calcification. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Harding,et al.  Characterization of GATA3 Mutations in the Hypoparathyroidism, Deafness, and Renal Dysplasia (HDR) Syndrome* , 2002, Journal of Biological Chemistry.

[24]  W. Murphy,et al.  Significant developmental elevation in serum parathyroid hormone levels in a large kindred with familial benign (hypocalciuric) hypercalcemia , 1993, Pediatric Nephrology.

[25]  C. Stewart,et al.  The laminopathies: nuclear structure meets disease. , 2003, Current opinion in genetics & development.

[26]  J. Benovic,et al.  Differential Roles of Arrestin-2 Interaction with Clathrin and Adaptor Protein 2 in G Protein-coupled Receptor Trafficking* , 2002, The Journal of Biological Chemistry.

[27]  P. Evans,et al.  Molecular Architecture and Functional Model of the Endocytic AP2 Complex , 2002, Cell.

[28]  E. Brown,et al.  Extracellular calcium sensing and extracellular calcium signaling. , 2001, Physiological reviews.

[29]  A. Sorkin,et al.  Inhibition of the receptor‐binding function of clathrin adaptor protein AP‐2 by dominant‐negative mutant μ2 subunit and its effects on endocytosis , 1999, The EMBO journal.

[30]  R. Thakker,et al.  Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13. , 1999, American journal of human genetics.

[31]  S. Kain,et al.  Use of coexpressed enhanced green fluorescent protein as a marker for identifying transfected cells. , 1999, Methods in enzymology.

[32]  J. Miller,et al.  Monoclonal Antibodies Against Synthetic Peptides Corresponding to the Extracellular Domain of the Human Ca2+ Receptor: Characterization and Use in Studying Concanavalin A Inhibition , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  E. Brown,et al.  Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells. , 1996, The Journal of clinical investigation.

[34]  S. Pearce,et al.  Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. , 1995, The Journal of clinical investigation.

[35]  J. Seidman,et al.  Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism , 1993, Cell.

[36]  M. Hediger,et al.  Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid , 1993, Nature.

[37]  M. Leppert,et al.  Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity. , 1993, American journal of human genetics.

[38]  G. Payne,et al.  AP17 and AP19, the mammalian small chains of the clathrin-associated protein complexes show homology to Yap17p, their putative homolog in yeast. , 1991, The Journal of biological chemistry.